InterSystems IRIS for Health Selected by Konica Minolta Japan for HL7® Rapid FHIR-Based Data Integration for Imaging Devices

InterSystems IRIS for Health is the world’s first and only data platform developed specifically for extracting value from medical data.

InterSystems IRIS for Health was selected by Konica Minolta Japan as the underlying technology for its new software systems that enable the Japanese tech giant’s devices to rapidly integrate patient data with other hospital systems.

Utilizing the HL7® FHIR® standard, the software supports the automated connection, visualization and use of medical data between Konica Minolta Japan’s devices and other hospital systems such as the electronic medical record (EMR).

InterSystems IRIS for Health is the world’s first and only data platform specifically engineered to extract value from healthcare data. On this platform, developers can create and scale healthcare applications with tools that are uniquely designed to meet the current and future needs of modern healthcare.

View video here.

Konica Minolta Japan is a mission-driven digital company offering a wide range of solutions spanning different markets. Within healthcare, the company provides diagnostic imaging and ultrasound systems, as well as solutions for centralized management and utilization of medical records for medical facilities, including filing, and document systems.

Under this agreement, InterSystems will provide IRIS for Health to Konica Minolta Japan to help their new system development that supports the automated connection, visualization and use of all medical data typically found scattered across various systems including electronic health records, diagnostic imaging, laboratory, document systems and more. Through this partnership, InterSystems supports Konica Minolta Japan’s aims to contribute to improved patient care quality and safety, in addition to efficiency gains.

“We are very pleased that InterSystems IRIS for Health’s HL7®FHIR® capability, the new standard for medical information exchange, and its ability to process medical data at high speed, have been highly regarded by Konica Minolta Japan and they’ve chosen InterSystems IRIS for Health as the core technology of their healthcare system development,” said Masane Hayashi, country manager for InterSystems in Japan.

Hayashi concluded, “Through the interoperability of FHIR and our support for the development of new systems that process and analyze vast amounts of medical information at high speed, we are pleased to help that the necessary information be delivered to the healthcare professionals who need it and to contribute in reducing alert fatigue among healthcare professionals, which is becoming an increasing social problem.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy